Ulf Mark Schneider

Fresenius Medical Care North America Names New Chief Medical Officer for Renal Therapies Group

Retrieved on: 
Thursday, April 23, 2020
Health, Fresenius, Societates Europaeae, Economy of Germany, Companies, Nephrology, Kidney, Diaverum, Ulf Mark Schneider

WALTHAM, Mass., April 23, 2020 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA) today announced the appointment of Dr. Michael Anger as Senior Vice President and Chief Medical Officer for the company's Renal Therapies Group, the leading provider of kidney care products in North America.

Key Points: 
  • WALTHAM, Mass., April 23, 2020 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA) today announced the appointment of Dr. Michael Anger as Senior Vice President and Chief Medical Officer for the company's Renal Therapies Group, the leading provider of kidney care products in North America.
  • Dr. Anger takes over the role from Dr. Robert Kossmann, who was promoted to Chief Medical Officer and Executive Vice President of FMCNA last year.
  • Dr.Angermost recently served as Chief Medical Officer of American Renal Associates, which operates dialysis clinics in 27 states and in Washington D.C. in partnership with about 400 nephrologists.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.

Fresenius Medical Care North America Highlights Home Growth and Telehealth Success

Retrieved on: 
Monday, April 6, 2020
Fresenius, Societates Europaeae, Economy of Germany, Companies, Health, Ulf Mark Schneider

WALTHAM, Mass., April 6, 2020 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, announced record growth of home therapies.

Key Points: 
  • WALTHAM, Mass., April 6, 2020 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, announced record growth of home therapies.
  • "Our success in growing home treatments is a direct result of our commitment to improving patient and physician education, and investing in technology to improve the home experience," said Bill Valle, Chief Executive Officer of Fresenius Medical Care North America.
  • The company continues to offer meaningful, educational information to the public through its Fresenius Kidney Care patient-facing website and its Fresenius Medical Care North America website.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.

Fresenius Medical Care North America Advances Home Dialysis with New Telehealth Solution

Retrieved on: 
Wednesday, February 26, 2020
Medicine, Clinical medicine, Health, Fresenius, Societates Europaeae, Membrane technology, Home hemodialysis, Telehealth, Dialysis, Ulf Mark Schneider

WALTHAM, Mass., Feb. 26, 2020 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, today announced the planned rollout of a new telehealth solution for its home dialysis patients.

Key Points: 
  • WALTHAM, Mass., Feb. 26, 2020 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, today announced the planned rollout of a new telehealth solution for its home dialysis patients.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.
  • Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Robert Ehrlich Joins Dialyze Direct's Strategic Advisory Board

Retrieved on: 
Wednesday, October 30, 2019
Medicine, Clinical medicine, Fresenius, Societates Europaeae, Home hemodialysis, Bob Ehrlich, Dialysis, Ulf Mark Schneider, Fresenius Medical Care

BROOKLYN, N.Y., Oct. 30, 2019 /PRNewswire/ --Dialyze Direct, a leading kidney care innovation company specializing in advancements in home dialysis service and technology, today announced that former Fresenius Chairman Robert Ehrlich has joined their Strategic Advisory Board.

Key Points: 
  • BROOKLYN, N.Y., Oct. 30, 2019 /PRNewswire/ --Dialyze Direct, a leading kidney care innovation company specializing in advancements in home dialysis service and technology, today announced that former Fresenius Chairman Robert Ehrlich has joined their Strategic Advisory Board.
  • Ehrlich is well known across industries for leading high-growth companies as they journey towards acquisition or public offering.
  • Having served for a decade as Chairman and CEO of Fresenius, the world's largest dialysis company, Ehrlich brings a rich knowledge of the dialysis industry and its history to Dialyze Direct.
  • During his tenure with the dialysis giant, Ehrlich grew its revenue from $16 million to $3 billion over the course of 10 years.

Fresenius Medical Care North America Launches TheHub Connected Health Platform

Retrieved on: 
Wednesday, October 30, 2019
Economy of Germany, Fresenius, Societates Europaeae, Companies, Industries, Ulf Mark Schneider, Draft:Rice Powell

WALTHAM, Mass., Oct. 30, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, has launched its new connected health platform called TheHub.

Key Points: 
  • WALTHAM, Mass., Oct. 30, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, has launched its new connected health platform called TheHub.
  • "This best-in-class solution offers a technology hub that improves the experience for patients and the entire care team," said Jeff Burbank, Chief Strategy and Transformation Officer for Fresenius Medical Care North America.
  • "This new suite of cloud applications is making our connected health technologies easier to use for providers and patients," said Dr. Robert Kossmann, Chief Medical Officer for Fresenius Medical Care North America.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.

Fresenius Medical Care Celebrates 10th Anniversary and Expansion of Their Dialysis Center With Enhanced Home Therapy Support in Perth, Western Australia

Retrieved on: 
Monday, October 28, 2019
Medical Supplies, Health, Medical devices, Practice Management, Other Health, General Health, Biotechnology, Health, Medicine, Membrane technology, Fresenius, Societates Europaeae, Renal dialysis, Home hemodialysis, Dialysis, Therapy, Ulf Mark Schneider

Fresenius Medical Care, the world's leading provider of dialysis products and services, announced the further enhancement of support for home dialysis patients in Western Australia.

Key Points: 
  • Fresenius Medical Care, the world's leading provider of dialysis products and services, announced the further enhancement of support for home dialysis patients in Western Australia.
  • Celebrating the 10th anniversary of the Fresenius Kidney Care Spearwood Dialysis Clinic in Perth this year, Fresenius Medical Care has expanded the facility with the addition of three home dialysis training rooms.
  • The Fresenius Medical Care management team, staff and patients celebrate 10th anniversary and expansion of Fresenius Kidney Care Spearwood Clinic with enhanced home therapy support in Perth, Western Australia.
  • Fresenius Medical Care has been working with local healthcare professionals, authorities and communities to help address this issue.

Fresenius Medical Care North America Responds To Signing of AB 290 in California

Retrieved on: 
Monday, October 14, 2019
Fresenius Medical Care, Economy of Germany, Fresenius, Companies, Industries, Draft:Rice Powell, Ulf Mark Schneider

WALTHAM, Mass., Oct. 14, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, released the following statement in response to the signing of AB 290 in California:

Key Points: 
  • WALTHAM, Mass., Oct. 14, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, released the following statement in response to the signing of AB 290 in California:
    "Fresenius Medical Care North America (FMCNA) is deeply saddened by Governor Newsom's decision to sign AB 290.
  • We stand ready to support these patients and continue to provide superior dialysis care both in-center and at home.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.
  • Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent.

Fresenius Medical Care North America Announces Leadership Additions Following NxStage Merger

Retrieved on: 
Monday, May 6, 2019
Companies, Fresenius, Societates Europaeae, Economy of Germany, NxStage, Economy of Europe, Ulf Mark Schneider

WALTHAM, Mass., May 6, 2019 /PRNewswire/ --Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, has announced organizational changes following its merger with NxStage Medical, Inc. As part of these changes, Jeff Burbank and Joe Turkhave joined the FMCNA senior leadership team in new roles that will help lead the company's innovation and expansion of home therapies.

Key Points: 
  • WALTHAM, Mass., May 6, 2019 /PRNewswire/ --Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, has announced organizational changes following its merger with NxStage Medical, Inc. As part of these changes, Jeff Burbank and Joe Turkhave joined the FMCNA senior leadership team in new roles that will help lead the company's innovation and expansion of home therapies.
  • "I'm thrilled that we are bringing these talented groups together under Jeff and Joe's leadership to ensure we continue to seamlessly integrate the incredible experience and groundbreaking technology from the NxStage team directly into Fresenius Medical Care North America," said Valle.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.
  • Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent.

Fresenius Medical Care Seeks Top Accreditation for Health Services in China

Retrieved on: 
Thursday, April 4, 2019
Health, Hospitals, Other Health, General Health, Fresenius, Societates Europaeae, Economy of Germany, Companies, Economy of Europe, Ulf Mark Schneider

Mr. Alan Chen, Executive Vice President of Greater China, Fresenius Medical Care, said Setting the benchmark for providing high-quality medical services has always been a priority for Fresenius Medical Care.

Key Points: 
  • Mr. Alan Chen, Executive Vice President of Greater China, Fresenius Medical Care, said Setting the benchmark for providing high-quality medical services has always been a priority for Fresenius Medical Care.
  • Fresenius Kidney Care, a division of Fresenius Medical Care, provides dialysis care services to more than 333,000 people with kidney disease at more than 3,900 facilities worldwide.
  • These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Fresenius Medical Care Announces Creation of Global Medical Office

Retrieved on: 
Wednesday, March 20, 2019
Companies, Fresenius Medical Care, Economy of Germany, Fresenius, Industries, Ulf Mark Schneider

In addition, Dr. Jeffrey Hymes, Chief Medical Officer for Fresenius Kidney Care, will expand his role to also serve as Senior Vice President of Clinical and Scientific Affairs for Fresenius Medical Care North America.

Key Points: 
  • In addition, Dr. Jeffrey Hymes, Chief Medical Officer for Fresenius Kidney Care, will expand his role to also serve as Senior Vice President of Clinical and Scientific Affairs for Fresenius Medical Care North America.
  • He joined Fresenius Medical Care in 2014, overseeing the clinical research, development and distribution of the company's products and pharmaceuticals throughout North America.
  • "The creation of a Global Medical Office under Dr. Maddux's leadership will help us coordinate the interpretation of clinical science and medical practice patterns on a global basis," said Bill Valle, CEO of Fresenius Medical Care North America.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.